PET imaging of PD-L1 with a small molecule radiotracer.
作者信息
Zhao Yajie, Hsu Jessica C, Hu Shuo, Cai Weibo
机构信息
Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders (Xiangya), Changsha, China.
出版信息
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1578-1581. doi: 10.1007/s00259-024-06663-4.
Abstract
摘要
相似文献
1
PET imaging of PD-L1 with a small molecule radiotracer.使用小分子放射性示踪剂对程序性死亡受体配体1（PD-L1）进行正电子发射断层显像（PET）。
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1578-1581. doi: 10.1007/s00259-024-06663-4.
2
In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.针对 PD-L1 的高亲和力亲和体 PET 示踪剂的体内评估和剂量估算。
Mol Imaging Biol. 2021 Apr;23(2):241-249. doi: 10.1007/s11307-020-01544-2. Epub 2020 Oct 23.
3
Site-Specific Immuno-PET Tracer to Image PD-L1.用于 PD-L1 成像的靶向免疫-PET 示踪剂。
Mol Pharm. 2019 May 6;16(5):2028-2036. doi: 10.1021/acs.molpharmaceut.9b00010. Epub 2019 Mar 25.
4
Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.用于人体免疫检查点成像的实用免疫正电子发射断层显像剂设计考量
J Nucl Med. 2017 Apr;58(4):538-546. doi: 10.2967/jnumed.116.177659. Epub 2016 Dec 15.
5
Development and evaluation of biphenyl-based small-molecule radiotracers for PET imaging of PD-L1 in tumor.用于肿瘤中PD-L1正电子发射断层显像（PET）成像的联苯类小分子放射性示踪剂的研发与评估
Bioorg Med Chem Lett. 2025 Jul 1;122:130187. doi: 10.1016/j.bmcl.2025.130187. Epub 2025 Mar 12.
6
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer F-BMS-986192.基于 Adnectin 的 PET 示踪剂 F-BMS-986192 对 PD-L1 表达和动态的分子成像。
J Nucl Med. 2020 Dec;61(12):1839-1844. doi: 10.2967/jnumed.119.241364. Epub 2020 May 1.
7
Synthesis and Biologic Evaluation of a Novel F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.新型 F 标记的衔接蛋白的合成及生物学评价，作为 PD-L1 表达的 PET 放射性配体。
J Nucl Med. 2018 Mar;59(3):529-535. doi: 10.2967/jnumed.117.199596. Epub 2017 Oct 12.
8
[F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [F]AlF-NOTA-WL12 in glioblastoma xenografts.[F]AlF-NOTA-PCP2：一种新型 PET/CT 示踪剂，用于增强 PD-L1 异质性成像，并与神经胶质瘤异种移植中的 [F]AlF-NOTA-WL12 进行比较分析。
Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3161-3175. doi: 10.1007/s00259-024-06743-5. Epub 2024 May 7.
9
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer.全身 PD-1 和 PD-L1 正电子发射断层扫描在非小细胞肺癌患者中的应用。
Nat Commun. 2018 Nov 7;9(1):4664. doi: 10.1038/s41467-018-07131-y.
10
A Novel Small Cyclic Peptide-Based Ga-Radiotracer for Positron Emission Tomography Imaging of PD-L1 Expression in Tumors.一种新型基于小环状肽的 Ga 放射性示踪剂，用于正电子发射断层扫描成像肿瘤中 PD-L1 的表达。
Mol Pharm. 2022 Jan 3;19(1):138-147. doi: 10.1021/acs.molpharmaceut.1c00694. Epub 2021 Dec 15.
引用本文的文献
1
68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study.68Ga-NK224 PET/CT用于PD-L1表达及肿瘤间异质性的无创评估：一项转化性探索性研究
Clin Cancer Res. 2025 Jul 15;31(14):2989-3001. doi: 10.1158/1078-0432.CCR-25-0160.
2
Preclinical and first‑in‑human evaluation of [Ga]Ga-DOTA-PEG-Asp-PDL1P PET imaging to assess tumor PD-L1 expression.[镓]Ga-DOTA-PEG-Asp-PDL1P PET成像用于评估肿瘤PD-L1表达的临床前和首次人体评估。
Eur J Nucl Med Mol Imaging. 2025 Mar 3. doi: 10.1007/s00259-025-07173-7.
3
Noninvasive Monitoring of Programmed Death-Ligand 2 Expression with Positron Emission Tomography using Ga-labeled Peptide Antagonist in Preclinical and Exploratory Human Studies.在临床前和探索性人体研究中使用镓标记的肽拮抗剂通过正电子发射断层扫描对程序性死亡配体2表达进行无创监测。
Research (Wash D C). 2024 Nov 1;7:0523. doi: 10.34133/research.0523. eCollection 2024.
本文引用的文献
1
Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics.开发基于小分子的放射性示踪剂，用于 PD-L1 表达的 PET 成像，并指导 PD-L1 治疗。
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1582-1592. doi: 10.1007/s00259-024-06610-3. Epub 2024 Jan 22.
2
Development, Characterization, and Radiation Dosimetry Studies of F-BMS-986229, a F-Labeled PD-L1 Macrocyclic Peptide PET Tracer.F-BMS-986229 是一种 F 标记的 PD-L1 大环肽 PET 示踪剂，本研究对其进行了开发、表征和辐射剂量学研究。
Mol Imaging Biol. 2024 Apr;26(2):301-309. doi: 10.1007/s11307-023-01889-4. Epub 2023 Dec 20.
3
The discovery and evaluation of [F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement.发现和评估 [F]BMS-986229，一种新型大环肽 PET 放射性配体，用于测量 PD-L1 表达和体内 PD-L1 靶标结合。
Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):978-990. doi: 10.1007/s00259-023-06527-3. Epub 2023 Dec 5.
4
[Ga]Ga-AUNP-12 PET imaging to assess the PD-L1 status in preclinical and first-in-human study.利用[镓]镓-金纳米颗粒-12正电子发射断层显像（PET）成像评估临床前和首次人体研究中的程序性死亡受体配体1（PD-L1）状态。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):369-379. doi: 10.1007/s00259-023-06447-2. Epub 2023 Sep 28.
5
Translational molecular imaging and drug development in Parkinson's disease.帕金森病的转化分子影像学与药物研发。
Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z.
6
CD8 T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.CD8 T 细胞内源性 IL-6 信号促进抗 PD-L1 免疫治疗的耐药性。
Cell Rep Med. 2023 Jan 17;4(1):100878. doi: 10.1016/j.xcrm.2022.100878. Epub 2023 Jan 3.
7
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial.阿替利珠单抗辅助治疗与安慰剂用于接受切除术治疗后复发风险增加的肾细胞癌患者（IMmotion010）：一项多中心、随机、双盲、III 期临床试验。
Lancet. 2022 Oct 1;400(10358):1103-1116. doi: 10.1016/S0140-6736(22)01658-0. Epub 2022 Sep 10.
8
From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades.从粗放到精准：PD-L1 评估预测 PD-1/PD-L1 阻断治疗的疗效。
Front Immunol. 2022 Aug 3;13:920021. doi: 10.3389/fimmu.2022.920021. eCollection 2022.
9
Preclinical and first-in-human evaluation of F-labeled D-peptide antagonist for PD-L1 status imaging with PET.用于 PD-L1 状态 PET 成像的 F 标记 D-肽拮抗剂的临床前和人体首次评估。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4312-4324. doi: 10.1007/s00259-022-05876-9. Epub 2022 Jul 14.
10
Immuno-PET imaging of PD-L1 expression in patient-derived lung cancer xenografts with [Ga]Ga-NOTA-Nb109.用[镓]镓-诺他-Nb109对患者来源的肺癌异种移植瘤中PD-L1表达进行免疫正电子发射断层扫描成像。
Quant Imaging Med Surg. 2022 Jun;12(6):3300-3313. doi: 10.21037/qims-21-991.
Zotero 插件